Outset Medical Inc. (OM)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 12, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Lost Money on Outset Medical, Inc.(OM)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Shareholder Rights Advocates at Levi & Korsinsky Investigate Outset Medical, Inc. (OM) Regarding Possible Securities Fraud Violations
NEW YORK, NY / ACCESSWIRE / August 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Outset Medical, Inc. (OM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK CITY, NY / ACCESSWIRE / August 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM). Investors who purchased Outset securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/OM.
Outset Medical, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - OM
NEW YORK, NY / ACCESSWIRE / August 10, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Lost Money on Outset Medical, Inc. (OM)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
OM Investors Can Join Outset Medical, Inc. Securities Fraud Investigation With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / August 9, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ: OM ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
Shareholders that Lost Money on Outset Medical, Inc. (OM) Should Contact Levi & Korsinsky About Securities Fraud Investigation - OM
NEW YORK, NY / ACCESSWIRE / August 9, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Levi & Korsinsky Announces an Investigation on Behalf of Outset Medical, Inc. (OM) Shareholders Who May Have Been Affected by Fraud
NEW YORK, NY / ACCESSWIRE / August 8, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Outset Medical, Inc. ("Outset Medical") (NASDAQ:OM) concerning possible violations of federal securities laws. Outset Medical reported its second-quarter financial results on August 7, 2024, revealing a notable decrease in revenue and a downward adjustment in its full-year guidance.
Why Is Outset Medical (OM) Stock Down 34% Today?
Outset Medical (NASDAQ: OM ) stock is taking a beating on Thursday after the medical technology company announced earnings results for the second quarter of the year. The Outset Medical earnings report starts with an adjusted EPS of -47 cents.
Outset Medical, Inc. (OM) Q2 2024 Earnings Call Transcript
Outset Medical, Inc. (NASDAQ:OM ) Q2 2024 Earnings Conference Call August 7, 2024 5:00 PM ET Company Participants Jim Mazzola - Head, Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officer Conference Call Participants Marie Thibault - BTIG Rick Wise - Stifel Shagun Sing - RBC Capital Markets Suraj Kalia - Oppenheimer Kristen Stewart - CL King Stephanie Piazzola - Bank of America Securities Drew Ranieri - Morgan Stanley Josh Jennings - TD Cowen Operator Ladies and gentlemen, thank you for standing by. Welcome to Outset Medical Second Quarter 2024 Earnings Conference Call.
Outset Medical, Inc. (OM) Reports Q2 Loss, Misses Revenue Estimates
Outset Medical, Inc. (OM) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to loss of $0.69 per share a year ago.
